Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Note on Taxation
Poorvu, William J.; Segel, Arthur I; Miller, Glenn S.; Krummer, Michael D.; Wu, Charles F; Sit, Po; Gerstel, Joseph M.Caso HBS-379192-EFinanzasEvery real-estate transaction is affected by the tax consequences that result from its form and substance. Structuring a transaction without a thorough understanding of its tax considerations is likely to reduce the transaction's potential value. The failure to utilize the available tax benefits eliminates one of the major reasons for making a real-estate investment.Desde 8,20 €
-
KTM - Venture Capitalist Exit
Stephen Sapp; Charlene Zietsma; Iris Fischlmayr; Rob WongCaso IVEY-9B07N003-EDirección estratégica, Finanzas, Iniciativa emprendedoraKTM is a small motorcycle manufacturing company located in Austria. As a result of difficult economic conditions in 1999, KTM went private with the help of the venture capital firm BC European Capital (BC). Following a couple of years of strong growth, BC is looking to liquidate its position and move on. KTM is faced with the decision of determining the best means to repurchase BC's equity position in the firm and leave the firm with enough finan...Desde 8,20 €
-
Business Succession and the Asher Estate - Teaching Note
Stephen Sapp; Alykhan AlidinaNota del Instructor IVEY-8B20N011-EFinanzasTeaching note for product 9B20N011.Desde 0,00 €
-
Magna International and Dual Share Unification - Teaching Note
W. Glenn Rowe; Stephen Sapp; Nadine de Gannes; Abbas KhambatiNota del Instructor IVEY-8B20M209-EDirección estratégicaTeaching note for product 9B20M209.Desde 0,00 €
-
CanniMed Therapeutics: Acquiror or Target
Stephen Sapp; Shane FreedmanCaso IVEY-9B20N008-EFinanzas, Iniciativa emprendedoraOn November 14, 2017, Aurora Cannabis Inc. (Aurora) made a proposal to CanniMed Therapeutics Inc. (CanniMed) to acquire all of CanniMed’s issued and outstanding common shares in a share exchange that valued CanniMed’s common shares at a premium of almostDesde 8,20 €
-
CS Publishing Inc.: Foreign Exchange Risk Management - Teaching Note
Stephen SappNota del Instructor IVEY-8B19N024-EFinanzasTeaching note for product 9B19N024.Desde 0,00 €
-
Experiencya Cuba: Two Entrepreneurs in Havana
Wu, Charles F; Cal, Mariana; Miguel, FernandaCaso HBS-220024-EEconomíaIn 2019, two Cuban entrepreneurs discussed their growth strategy, given the regulatory framework instability, for private companies, in Cuba. Experiencya Cuba offered car and apartment rentals, airport pick-up, and tours around the island, all conducted in perfectly restored American cars from the 1950s.Desde 8,20 €
-
CanniMed Therapeutics: Acquiror or Target - Teaching Note
Stephen SappNota del Instructor IVEY-8B20N008-EFinanzasTeaching note for product 9B20N008.Desde 0,00 €
-
Hydro One Inc.: CEO Compensation
Stephen Sapp; Ramasastry ChandrasekharCaso IVEY-9B10N002-EContabilidad y control, Dirección estratégica, Finanzas, Liderazgo y Dirección de personasThe case presents the situation faced by the board of directors at Hydro One, a government-owned Canadian electric utility, as they discuss updating the current executive compensation packages because of the pending privatization of Hydro One. As a government owned enterprise, compensation was moderated by the job security and prospects of career advancement in the public sector, but the imminent privatization required the compensation system to ...Desde 8,20 €
-
JP Morgan: Lessons Learned
Stephen SappCaso IVEY-9B12N024-EFinanzasFollowing the revelation of a US$2 billion loss on trading at JP Morgan’s chief investment office (CIO) in London, the company’s board of directors is tasked with recommending changes to its risk management practices and corporate governance structure. The case provides background on JP Morgan's well-respected risk management infrastructure and discusses how the CEO focused on its historic strength in risk management to argue against the need for...Desde 8,20 €